From Clinical Trial to Commercialization

Nov 03, 2016 at 03:07 pm by Staff

It's a long road with many speed bumps along the way when making the journey from drug development to approval and commercialization, but Nashville-based Cumberland Pharmaceut.... Read More

FDA Approves Device for Prevention of Recurrent Stroke in PFO Patients

Oct 31, 2016 at 09:00 am by Staff

On Oct. 28, the U.S. Food and Drug Administration approved the Amplatzer PFO Occluder device. The PFO Occluder reduces the risk of a stroke in patients who previously had a st.... Read More